 | • レポートコード：MRC2-11QY12995 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は獣医/動物用ワクチンのグローバル市場について調査・分析したレポートです。種類別（弱毒生ワクチン、不活化ワクチン、トキソイドワクチン、組換えワクチン、その他ワクチン）市場規模、用途別（病院・診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別獣医/動物用ワクチンの競争状況、市場シェア ・世界の獣医/動物用ワクチン市場：種類別市場規模 2015年-2020年（弱毒生ワクチン、不活化ワクチン、トキソイドワクチン、組換えワクチン、その他ワクチン） ・世界の獣医/動物用ワクチン市場：種類別市場規模予測 2021年-2026年（弱毒生ワクチン、不活化ワクチン、トキソイドワクチン、組換えワクチン、その他ワクチン） ・世界の獣医/動物用ワクチン市場：用途別市場規模 2015年-2020年（病院・診療所、その他） ・世界の獣医/動物用ワクチン市場：用途別市場規模予測 2021年-2026年（病院・診療所、その他） ・北米の獣医/動物用ワクチン市場分析：米国、カナダ ・ヨーロッパの獣医/動物用ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの獣医/動物用ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の獣医/動物用ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの獣医/動物用ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Zoetis、Merck Animal Health、Boehringer Ingelheim、Elanco、Virbac、Vetoquinol、Phibro Animal Health、Hester、Hipra、Idt Biologika、Biogenesis Bago、Tianjin Ringpu、China Animal Husbandry ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines on the basis of technology.
In 2017, in terms of value, Europe is expected to account for the largest share of the global animal vaccines market, followed by North America. However, the Asia Pacific region is expected to register the highest growth during the forecast period.
Market Analysis and Insights: Global Veterinary/Animal Vaccines Market
The global Veterinary/Animal Vaccines market size is projected to reach US$ 6625.1 million by 2026, from US$ 6375.7 million in 2020, at a CAGR of 3.6%% during 2021-2026.
Global Veterinary/Animal Vaccines Scope and Market Size
Veterinary/Animal Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary/Animal Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Veterinary/Animal Vaccines market is segmented into
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines
Segment by Application, the Veterinary/Animal Vaccines market is segmented into
Hospitals and Clinics
Others
Regional and Country-level Analysis
The Veterinary/Animal Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Veterinary/Animal Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Veterinary/Animal Vaccines Market Share Analysis
Veterinary/Animal Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Veterinary/Animal Vaccines business, the date to enter into the Veterinary/Animal Vaccines market, Veterinary/Animal Vaccines product introduction, recent developments, etc.
The major vendors covered:
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco
Virbac
Vetoquinol
Phibro Animal Health
Hester
Hipra
Idt Biologika
Biogenesis Bago
Tianjin Ringpu
China Animal Husbandry
1 Study Coverage
1.1 Veterinary/Animal Vaccines Product Introduction
1.2 Market Segments
1.3 Key Veterinary/Animal Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Veterinary/Animal Vaccines Market Size Growth Rate by Type
1.4.2 Live Attenuated Vaccines
1.4.3 Inactivated Vaccines
1.4.4 Toxoid Vaccines
1.4.5 Recombinant Vaccines
1.4.6 Other Vaccines
1.5 Market by Application
1.5.1 Global Veterinary/Animal Vaccines Market Size Growth Rate by Application
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Veterinary/Animal Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Veterinary/Animal Vaccines Revenue 2015-2026
2.1.2 Global Veterinary/Animal Vaccines Sales 2015-2026
2.2 Global Veterinary/Animal Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Veterinary/Animal Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Veterinary/Animal Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Veterinary/Animal Vaccines Competitor Landscape by Players
3.1 Veterinary/Animal Vaccines Sales by Manufacturers
3.1.1 Veterinary/Animal Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Veterinary/Animal Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Veterinary/Animal Vaccines Revenue by Manufacturers
3.2.1 Veterinary/Animal Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Veterinary/Animal Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Veterinary/Animal Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Veterinary/Animal Vaccines Revenue in 2019
3.2.5 Global Veterinary/Animal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Veterinary/Animal Vaccines Price by Manufacturers
3.4 Veterinary/Animal Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Veterinary/Animal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary/Animal Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Veterinary/Animal Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Veterinary/Animal Vaccines Market Size by Type (2015-2020)
4.1.1 Global Veterinary/Animal Vaccines Sales by Type (2015-2020)
4.1.2 Global Veterinary/Animal Vaccines Revenue by Type (2015-2020)
4.1.3 Veterinary/Animal Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Veterinary/Animal Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Veterinary/Animal Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Veterinary/Animal Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Veterinary/Animal Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Veterinary/Animal Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Veterinary/Animal Vaccines Market Size by Application (2015-2020)
5.1.1 Global Veterinary/Animal Vaccines Sales by Application (2015-2020)
5.1.2 Global Veterinary/Animal Vaccines Revenue by Application (2015-2020)
5.1.3 Veterinary/Animal Vaccines Price by Application (2015-2020)
5.2 Veterinary/Animal Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Veterinary/Animal Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Veterinary/Animal Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Veterinary/Animal Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Veterinary/Animal Vaccines by Country
6.1.1 North America Veterinary/Animal Vaccines Sales by Country
6.1.2 North America Veterinary/Animal Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Veterinary/Animal Vaccines Market Facts & Figures by Type
6.3 North America Veterinary/Animal Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Veterinary/Animal Vaccines by Country
7.1.1 Europe Veterinary/Animal Vaccines Sales by Country
7.1.2 Europe Veterinary/Animal Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Veterinary/Animal Vaccines Market Facts & Figures by Type
7.3 Europe Veterinary/Animal Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Veterinary/Animal Vaccines by Region
8.1.1 Asia Pacific Veterinary/Animal Vaccines Sales by Region
8.1.2 Asia Pacific Veterinary/Animal Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Veterinary/Animal Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Veterinary/Animal Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Veterinary/Animal Vaccines by Country
9.1.1 Latin America Veterinary/Animal Vaccines Sales by Country
9.1.2 Latin America Veterinary/Animal Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Veterinary/Animal Vaccines Market Facts & Figures by Type
9.3 Central & South America Veterinary/Animal Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Veterinary/Animal Vaccines by Country
10.1.1 Middle East and Africa Veterinary/Animal Vaccines Sales by Country
10.1.2 Middle East and Africa Veterinary/Animal Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Veterinary/Animal Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Veterinary/Animal Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description and Business Overview
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Veterinary/Animal Vaccines Products Offered
11.1.5 Zoetis Related Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Corporation Information
11.2.2 Merck Animal Health Description and Business Overview
11.2.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Animal Health Veterinary/Animal Vaccines Products Offered
11.2.5 Merck Animal Health Related Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Description and Business Overview
11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Veterinary/Animal Vaccines Products Offered
11.3.5 Boehringer Ingelheim Related Developments
11.4 Elanco
11.4.1 Elanco Corporation Information
11.4.2 Elanco Description and Business Overview
11.4.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Elanco Veterinary/Animal Vaccines Products Offered
11.4.5 Elanco Related Developments
11.5 Virbac
11.5.1 Virbac Corporation Information
11.5.2 Virbac Description and Business Overview
11.5.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Virbac Veterinary/Animal Vaccines Products Offered
11.5.5 Virbac Related Developments
11.6 Vetoquinol
11.6.1 Vetoquinol Corporation Information
11.6.2 Vetoquinol Description and Business Overview
11.6.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Vetoquinol Veterinary/Animal Vaccines Products Offered
11.6.5 Vetoquinol Related Developments
11.7 Phibro Animal Health
11.7.1 Phibro Animal Health Corporation Information
11.7.2 Phibro Animal Health Description and Business Overview
11.7.3 Phibro Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Phibro Animal Health Veterinary/Animal Vaccines Products Offered
11.7.5 Phibro Animal Health Related Developments
11.8 Hester
11.8.1 Hester Corporation Information
11.8.2 Hester Description and Business Overview
11.8.3 Hester Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Hester Veterinary/Animal Vaccines Products Offered
11.8.5 Hester Related Developments
11.9 Hipra
11.9.1 Hipra Corporation Information
11.9.2 Hipra Description and Business Overview
11.9.3 Hipra Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hipra Veterinary/Animal Vaccines Products Offered
11.9.5 Hipra Related Developments
11.10 Idt Biologika
11.10.1 Idt Biologika Corporation Information
11.10.2 Idt Biologika Description and Business Overview
11.10.3 Idt Biologika Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Idt Biologika Veterinary/Animal Vaccines Products Offered
11.10.5 Idt Biologika Related Developments
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description and Business Overview
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Veterinary/Animal Vaccines Products Offered
11.1.5 Zoetis Related Developments
11.12 Tianjin Ringpu
11.12.1 Tianjin Ringpu Corporation Information
11.12.2 Tianjin Ringpu Description and Business Overview
11.12.3 Tianjin Ringpu Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Tianjin Ringpu Products Offered
11.12.5 Tianjin Ringpu Related Developments
11.13 China Animal Husbandry
11.13.1 China Animal Husbandry Corporation Information
11.13.2 China Animal Husbandry Description and Business Overview
11.13.3 China Animal Husbandry Sales, Revenue and Gross Margin (2015-2020)
11.13.4 China Animal Husbandry Products Offered
11.13.5 China Animal Husbandry Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Veterinary/Animal Vaccines Market Estimates and Projections by Region
12.1.1 Global Veterinary/Animal Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Veterinary/Animal Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Veterinary/Animal Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Veterinary/Animal Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Veterinary/Animal Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Veterinary/Animal Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Veterinary/Animal Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Veterinary/Animal Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Veterinary/Animal Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Veterinary/Animal Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Veterinary/Animal Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Veterinary/Animal Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Veterinary/Animal Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Veterinary/Animal Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Veterinary/Animal Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Veterinary/Animal Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Veterinary/Animal Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Veterinary/Animal Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Veterinary/Animal Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Veterinary/Animal Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Veterinary/Animal Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Veterinary/Animal Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Veterinary/Animal Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Veterinary/Animal Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Veterinary/Animal Vaccines Market Segments
Table 2. Ranking of Global Top Veterinary/Animal Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Veterinary/Animal Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Live Attenuated Vaccines
Table 5. Major Manufacturers of Inactivated Vaccines
Table 6. Major Manufacturers of Toxoid Vaccines
Table 7. Major Manufacturers of Recombinant Vaccines
Table 8. Major Manufacturers of Other Vaccines
Table 9. Global Veterinary/Animal Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Veterinary/Animal Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Veterinary/Animal Vaccines Sales by Regions 2015-2020 (K Units)
Table 12. Global Veterinary/Animal Vaccines Sales Market Share by Regions (2015-2020)
Table 13. Global Veterinary/Animal Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Veterinary/Animal Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Veterinary/Animal Vaccines Sales Share by Manufacturers (2015-2020)
Table 16. Global Veterinary/Animal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Veterinary/Animal Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary/Animal Vaccines as of 2019)
Table 18. Veterinary/Animal Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Veterinary/Animal Vaccines Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Veterinary/Animal Vaccines Price (2015-2020) (USD/Unit)
Table 21. Veterinary/Animal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Veterinary/Animal Vaccines Product Type
Table 23. Date of International Manufacturers Enter into Veterinary/Animal Vaccines Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Veterinary/Animal Vaccines Sales by Type (2015-2020) (K Units)
Table 26. Global Veterinary/Animal Vaccines Sales Share by Type (2015-2020)
Table 27. Global Veterinary/Animal Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Veterinary/Animal Vaccines Revenue Share by Type (2015-2020)
Table 29. Veterinary/Animal Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Veterinary/Animal Vaccines Sales by Application (2015-2020) (K Units)
Table 31. Global Veterinary/Animal Vaccines Sales Share by Application (2015-2020)
Table 32. North America Veterinary/Animal Vaccines Sales by Country (2015-2020) (K Units)
Table 33. North America Veterinary/Animal Vaccines Sales Market Share by Country (2015-2020)
Table 34. North America Veterinary/Animal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Veterinary/Animal Vaccines Revenue Market Share by Country (2015-2020)
Table 36. North America Veterinary/Animal Vaccines Sales by Type (2015-2020) (K Units)
Table 37. North America Veterinary/Animal Vaccines Sales Market Share by Type (2015-2020)
Table 38. North America Veterinary/Animal Vaccines Sales by Application (2015-2020) (K Units)
Table 39. North America Veterinary/Animal Vaccines Sales Market Share by Application (2015-2020)
Table 40. Europe Veterinary/Animal Vaccines Sales by Country (2015-2020) (K Units)
Table 41. Europe Veterinary/Animal Vaccines Sales Market Share by Country (2015-2020)
Table 42. Europe Veterinary/Animal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Veterinary/Animal Vaccines Revenue Market Share by Country (2015-2020)
Table 44. Europe Veterinary/Animal Vaccines Sales by Type (2015-2020) (K Units)
Table 45. Europe Veterinary/Animal Vaccines Sales Market Share by Type (2015-2020)
Table 46. Europe Veterinary/Animal Vaccines Sales by Application (2015-2020) (K Units)
Table 47. Europe Veterinary/Animal Vaccines Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Veterinary/Animal Vaccines Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Veterinary/Animal Vaccines Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Veterinary/Animal Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Veterinary/Animal Vaccines Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Veterinary/Animal Vaccines Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Veterinary/Animal Vaccines Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Veterinary/Animal Vaccines Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Veterinary/Animal Vaccines Sales Market Share by Application (2015-2020)
Table 56. Latin America Veterinary/Animal Vaccines Sales by Country (2015-2020) (K Units)
Table 57. Latin America Veterinary/Animal Vaccines Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Veterinary/Animal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Veterinary/Animal Vaccines Revenue Market Share by Country (2015-2020)
Table 60. Latin America Veterinary/Animal Vaccines Sales by Type (2015-2020) (K Units)
Table 61. Latin America Veterinary/Animal Vaccines Sales Market Share by Type (2015-2020)
Table 62. Latin America Veterinary/Animal Vaccines Sales by Application (2015-2020) (K Units)
Table 63. Latin America Veterinary/Animal Vaccines Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Veterinary/Animal Vaccines Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Veterinary/Animal Vaccines Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Veterinary/Animal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Veterinary/Animal Vaccines Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Veterinary/Animal Vaccines Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Veterinary/Animal Vaccines Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Veterinary/Animal Vaccines Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Veterinary/Animal Vaccines Sales Market Share by Application (2015-2020)
Table 72. Zoetis Corporation Information
Table 73. Zoetis Description and Major Businesses
Table 74. Zoetis Veterinary/Animal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Zoetis Product
Table 76. Zoetis Recent Development
Table 77. Merck Animal Health Corporation Information
Table 78. Merck Animal Health Description and Major Businesses
Table 79. Merck Animal Health Veterinary/Animal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Merck Animal Health Product
Table 81. Merck Animal Health Recent Development
Table 82. Boehringer Ingelheim Corporation Information
Table 83. Boehringer Ingelheim Description and Major Businesses
Table 84. Boehringer Ingelheim Veterinary/Animal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Boehringer Ingelheim Product
Table 86. Boehringer Ingelheim Recent Development
Table 87. Elanco Corporation Information
Table 88. Elanco Description and Major Businesses
Table 89. Elanco Veterinary/Animal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Elanco Product
Table 91. Elanco Recent Development
Table 92. Virbac Corporation Information
Table 93. Virbac Description and Major Businesses
Table 94. Virbac Veterinary/Animal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Virbac Product
Table 96. Virbac Recent Development
Table 97. Vetoquinol Corporation Information
Table 98. Vetoquinol Description and Major Businesses
Table 99. Vetoquinol Veterinary/Animal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Vetoquinol Product
Table 101. Vetoquinol Recent Development
Table 102. Phibro Animal Health Corporation Information
Table 103. Phibro Animal Health Description and Major Businesses
Table 104. Phibro Animal Health Veterinary/Animal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Phibro Animal Health Product
Table 106. Phibro Animal Health Recent Development
Table 107. Hester Corporation Information
Table 108. Hester Description and Major Businesses
Table 109. Hester Veterinary/Animal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Hester Product
Table 111. Hester Recent Development
Table 112. Hipra Corporation Information
Table 113. Hipra Description and Major Businesses
Table 114. Hipra Veterinary/Animal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Hipra Product
Table 116. Hipra Recent Development
Table 117. Idt Biologika Corporation Information
Table 118. Idt Biologika Description and Major Businesses
Table 119. Idt Biologika Veterinary/Animal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Idt Biologika Product
Table 121. Idt Biologika Recent Development
Table 122. Biogenesis Bago Corporation Information
Table 123. Biogenesis Bago Description and Major Businesses
Table 124. Biogenesis Bago Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. Biogenesis Bago Product
Table 126. Biogenesis Bago Recent Development
Table 127. Tianjin Ringpu Corporation Information
Table 128. Tianjin Ringpu Description and Major Businesses
Table 129. Tianjin Ringpu Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Tianjin Ringpu Product
Table 131. Tianjin Ringpu Recent Development
Table 132. China Animal Husbandry Corporation Information
Table 133. China Animal Husbandry Description and Major Businesses
Table 134. China Animal Husbandry Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 135. China Animal Husbandry Product
Table 136. China Animal Husbandry Recent Development
Table 137. Global Veterinary/Animal Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 138. Global Veterinary/Animal Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 139. Global Veterinary/Animal Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 140. Global Veterinary/Animal Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 141. North America: Veterinary/Animal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 142. North America: Veterinary/Animal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Europe: Veterinary/Animal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 144. Europe: Veterinary/Animal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Asia Pacific: Veterinary/Animal Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 146. Asia Pacific: Veterinary/Animal Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 147. Latin America: Veterinary/Animal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 148. Latin America: Veterinary/Animal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Middle East and Africa: Veterinary/Animal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 150. Middle East and Africa: Veterinary/Animal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 152. Key Challenges
Table 153. Market Risks
Table 154. Main Points Interviewed from Key Veterinary/Animal Vaccines Players
Table 155. Veterinary/Animal Vaccines Customers List
Table 156. Veterinary/Animal Vaccines Distributors List
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary/Animal Vaccines Product Picture
Figure 2. Global Veterinary/Animal Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Live Attenuated Vaccines Product Picture
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Toxoid Vaccines Product Picture
Figure 6. Recombinant Vaccines Product Picture
Figure 7. Other Vaccines Product Picture
Figure 8. Global Veterinary/Animal Vaccines Sales Market Share by Application in 2020 & 2026
Figure 9. Hospitals and Clinics
Figure 10. Others
Figure 11. Veterinary/Animal Vaccines Report Years Considered
Figure 12. Global Veterinary/Animal Vaccines Market Size 2015-2026 (US$ Million)
Figure 13. Global Veterinary/Animal Vaccines Sales 2015-2026 (K Units)
Figure 14. Global Veterinary/Animal Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Veterinary/Animal Vaccines Sales Market Share by Region (2015-2020)
Figure 16. Global Veterinary/Animal Vaccines Sales Market Share by Region in 2019
Figure 17. Global Veterinary/Animal Vaccines Revenue Market Share by Region (2015-2020)
Figure 18. Global Veterinary/Animal Vaccines Revenue Market Share by Region in 2019
Figure 19. Global Veterinary/Animal Vaccines Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Veterinary/Animal Vaccines Revenue in 2019
Figure 21. Veterinary/Animal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Veterinary/Animal Vaccines Sales Market Share by Type (2015-2020)
Figure 23. Global Veterinary/Animal Vaccines Sales Market Share by Type in 2019
Figure 24. Global Veterinary/Animal Vaccines Revenue Market Share by Type (2015-2020)
Figure 25. Global Veterinary/Animal Vaccines Revenue Market Share by Type in 2019
Figure 26. Global Veterinary/Animal Vaccines Market Share by Price Range (2015-2020)
Figure 27. Global Veterinary/Animal Vaccines Sales Market Share by Application (2015-2020)
Figure 28. Global Veterinary/Animal Vaccines Sales Market Share by Application in 2019
Figure 29. Global Veterinary/Animal Vaccines Revenue Market Share by Application (2015-2020)
Figure 30. Global Veterinary/Animal Vaccines Revenue Market Share by Application in 2019
Figure 31. North America Veterinary/Animal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Veterinary/Animal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Veterinary/Animal Vaccines Sales Market Share by Country in 2019
Figure 34. North America Veterinary/Animal Vaccines Revenue Market Share by Country in 2019
Figure 35. U.S. Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Veterinary/Animal Vaccines Market Share by Type in 2019
Figure 40. North America Veterinary/Animal Vaccines Market Share by Application in 2019
Figure 41. Europe Veterinary/Animal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Veterinary/Animal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Veterinary/Animal Vaccines Sales Market Share by Country in 2019
Figure 44. Europe Veterinary/Animal Vaccines Revenue Market Share by Country in 2019
Figure 45. Germany Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Veterinary/Animal Vaccines Market Share by Type in 2019
Figure 56. Europe Veterinary/Animal Vaccines Market Share by Application in 2019
Figure 57. Asia Pacific Veterinary/Animal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Veterinary/Animal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Veterinary/Animal Vaccines Sales Market Share by Region in 2019
Figure 60. Asia Pacific Veterinary/Animal Vaccines Revenue Market Share by Region in 2019
Figure 61. China Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Veterinary/Animal Vaccines Market Share by Type in 2019
Figure 84. Asia Pacific Veterinary/Animal Vaccines Market Share by Application in 2019
Figure 85. Latin America Veterinary/Animal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Veterinary/Animal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Veterinary/Animal Vaccines Sales Market Share by Country in 2019
Figure 88. Latin America Veterinary/Animal Vaccines Revenue Market Share by Country in 2019
Figure 89. Mexico Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Veterinary/Animal Vaccines Market Share by Type in 2019
Figure 96. Latin America Veterinary/Animal Vaccines Market Share by Application in 2019
Figure 97. Middle East and Africa Veterinary/Animal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Veterinary/Animal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Veterinary/Animal Vaccines Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Veterinary/Animal Vaccines Revenue Market Share by Country in 2019
Figure 101. Turkey Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Veterinary/Animal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Veterinary/Animal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Veterinary/Animal Vaccines Market Share by Type in 2019
Figure 108. Middle East and Africa Veterinary/Animal Vaccines Market Share by Application in 2019
Figure 109. North America Veterinary/Animal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Veterinary/Animal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Veterinary/Animal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Veterinary/Animal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Veterinary/Animal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Veterinary/Animal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Veterinary/Animal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Veterinary/Animal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Veterinary/Animal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Veterinary/Animal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
獣医用ワクチンの世界市場（～2026年） Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock product…- コンパニオンアニマル用ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Companion Animal Vaccines Market The global Companion Animal Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Companion Animal Vaccines Scope and Market Size Companion Anima…
- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…
- フルミストワクチンの世界市場（～2026年） An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…